Skip to content
Parakho

Q1 FY27, unaudited

Revenue
₹322.84 Cr
Profit after tax
₹32.66 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations322.84+15.23%431.60
Other income1.90+7.71%7.81
Total income324.74+15.18%439.41
Employee benefit expense10.36+14.46%33.33
Finance costs3.79+31.25%13.31
Depreciation & amortisation1.01+3.08%3.95
Total expenses292.57+19.35%396.32
Profit before tax33.38−14.12%49.10
Tax expense0.72+9.28%4.67
Profit after tax32.66−14.52%44.43
Total comprehensive income32.68−14.29%44.50
Earnings per share
Earnings per share, basic₹17.18₹23.42
Earnings per share, diluted₹17.18₹23.42

Q1 FY27 unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base unaudited, from the company’s filing with NSE. Source

FY26 from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Nath Bio-Genes reported FY26 revenue of INR 4,316 million, up 19% YoY, with EBITDA of INR 525 million at a 12% margin and PAT of INR 384 million at a 9% margin. Management highlighted 22.35% volume growth in cotton, 25% volume growth in paddy, and a 54% volume surge in maize, alongside a first-time INR 15 crore contribution from its Uzbekistan joint venture. Gross margin normalized to 56% from an elevated 63-64% in FY25 due to a richer product and market mix, and management discussed inventory build-up, El Nino preparedness, and plans for FY27 growth.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 16 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 06 Aug 2026.